314 related articles for article (PubMed ID: 30014799)
1. Recent Advances in Probiotics as Live Biotherapeutics Against Gastrointestinal Diseases.
Kota RK; Ambati RR; Y V V AK; Srirama K; Reddy PN
Curr Pharm Des; 2018; 24(27):3162-3171. PubMed ID: 30014799
[TBL] [Abstract][Full Text] [Related]
2. Probiotics in the mechanism of protection against gut inflammation and therapy of gastrointestinal disorders.
Dylag K; Hubalewska-Mazgaj M; Surmiak M; Szmyd J; Brzozowski T
Curr Pharm Des; 2014; 20(7):1149-55. PubMed ID: 23755726
[TBL] [Abstract][Full Text] [Related]
3. Gut to brain interaction in Autism Spectrum Disorders: a randomized controlled trial on the role of probiotics on clinical, biochemical and neurophysiological parameters.
Santocchi E; Guiducci L; Fulceri F; Billeci L; Buzzigoli E; Apicella F; Calderoni S; Grossi E; Morales MA; Muratori F
BMC Psychiatry; 2016 Jun; 16():183. PubMed ID: 27260271
[TBL] [Abstract][Full Text] [Related]
4. Role of Lactic Acid Probiotic Bacteria in IBD.
Vemuri R; Gundamaraju R; Eri R
Curr Pharm Des; 2017; 23(16):2352-2355. PubMed ID: 28176664
[TBL] [Abstract][Full Text] [Related]
5. Microbial modulation of the gut microbiome for treating autoimmune diseases.
Balakrishnan B; Taneja V
Expert Rev Gastroenterol Hepatol; 2018 Oct; 12(10):985-996. PubMed ID: 30146910
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in Clinical Utility of Probiotics in Gastrointestinal Tract Disorders.
Biswasroy P; Pradhan D; Sahu DK; Sahu A; Ghosh G; Rath G
Curr Pharm Biotechnol; 2021; 22(12):1559-1573. PubMed ID: 33121407
[TBL] [Abstract][Full Text] [Related]
7. Probiotic supplementation in children with cystic fibrosis-a systematic review.
Ananthan A; Balasubramanian H; Rao S; Patole S
Eur J Pediatr; 2016 Oct; 175(10):1255-66. PubMed ID: 27576473
[TBL] [Abstract][Full Text] [Related]
8. Pre- and probiotic overview.
Cremon C; Barbaro MR; Ventura M; Barbara G
Curr Opin Pharmacol; 2018 Dec; 43():87-92. PubMed ID: 30219638
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Probiotics on Gut Microbiota during the Helicobacter pylori Eradication: Randomized Controlled Trial.
Oh B; Kim BS; Kim JW; Kim JS; Koh SJ; Kim BG; Lee KL; Chun J
Helicobacter; 2016 Jun; 21(3):165-74. PubMed ID: 26395781
[TBL] [Abstract][Full Text] [Related]
10. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
[TBL] [Abstract][Full Text] [Related]
11. Probiotics as drugs against human gastrointestinal infections.
Sanz Y; Nadal I; Sánchez E
Recent Pat Antiinfect Drug Discov; 2007 Jun; 2(2):148-56. PubMed ID: 18221171
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal cancers: influence of gut microbiota, probiotics and prebiotics.
Serban DE
Cancer Lett; 2014 Apr; 345(2):258-70. PubMed ID: 23981580
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
Vemuri RC; Gundamaraju R; Shinde T; Eri R
Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
[TBL] [Abstract][Full Text] [Related]
14. Dysbiosis in Functional Bowel Disorders.
Enck P; Mazurak N
Ann Nutr Metab; 2018; 72(4):296-306. PubMed ID: 29694952
[TBL] [Abstract][Full Text] [Related]
15. Next generation probiotics: Engineering live biotherapeutics.
Murali SK; Mansell TJ
Biotechnol Adv; 2024; 72():108336. PubMed ID: 38432422
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota and functional diseases of the gastrointestinal tract.
Imperatore N; Tortora R; Morisco F; Caporaso N
Minerva Gastroenterol Dietol; 2017 Dec; 63(4):355-372. PubMed ID: 27849120
[TBL] [Abstract][Full Text] [Related]
17. Probiotics as potential biotherapeutics in the management of type 2 diabetes - prospects and perspectives.
Panwar H; Rashmi HM; Batish VK; Grover S
Diabetes Metab Res Rev; 2013 Feb; 29(2):103-12. PubMed ID: 23225499
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota and probiotics: novel immune system modulators in myasthenia gravis?
Rinaldi E; Consonni A; Guidesi E; Elli M; Mantegazza R; Baggi F
Ann N Y Acad Sci; 2018 Feb; 1413(1):49-58. PubMed ID: 29341125
[TBL] [Abstract][Full Text] [Related]
19. Dietary Additive Probiotics Modulation of the Intestinal Microbiota.
Hu S; Wang L; Jiang Z
Protein Pept Lett; 2017; 24(5):382-387. PubMed ID: 28240160
[TBL] [Abstract][Full Text] [Related]
20. Do probiotics have a therapeutic role in gastroenterology?
Limdi JK; O'Neill C; McLaughlin J
World J Gastroenterol; 2006 Sep; 12(34):5447-57. PubMed ID: 17006980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
